Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03023566 · ClinicalTrials.gov registry record
Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI
A clinical trial, sponsored by Phoenix Children's Hospital.
- Completed
- Registry status
- 250
- Enrollment target
NCT03023566 is a clinical trial that has completed, run by Phoenix Children's Hospital. The registered enrollment target is 250 participants.
The verdict
NCT03023566 has completed, sponsored by Phoenix Children's Hospital.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate safety and efficacy of Dotarem enhanced MRI in pediatric and neonatal population who are referred for contrast enhanced MRI at Phoenix Children's Hospital.
Interventions
- DRUG Dotarem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2017-02-09 |
| Est. Completion | 2017-11-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03023566
The ClinicalTrials.gov registry entry for NCT03023566 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phoenix Children's Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dotarem is the first listed.
NCT03023566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03023566 about?
NCT03023566 is a clinical study titled "Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI". The goal of this study is to evaluate safety and efficacy of Dotarem enhanced MRI in pediatric and neonatal population who are referred for contrast enhanced MRI at Phoenix Children's Hospital.
What is the current status of trial NCT03023566?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2017-02-09. Estimated completion is 2017-11-12.
What interventions are being tested in trial NCT03023566?
The interventions under investigation include: Dotarem (DRUG).
Who is sponsoring clinical trial NCT03023566?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.